For the Inventor, By the Inventor

Enter assignee name

Franfurt am Main, Germany

Aventis Pharma Deutschland, Gmbh

USPTO Granted Patents = 330

CIPO Patents = 2

EPO Patents = 1

Trademarks = 6

Forward Citations = 3,420

Loading Chart...

Loading Chart...

433 inventors (with patents filed for the assignee):

Martin Bickel (29 out of 65 patents)

Gerhard Jaehne (25 out of 59 patents)

Hans-Jochen Lang (22 out of 108 patents)

4. Heiner Glombik (22 out of 75 patents)

5. Heinz-Werner Kleemann (20 out of 103 patents)

6. Hartmut Strobel (18 out of 54 patents)

7. Matthias Gossel (18 out of 46 patents)

8. Wendelin Frick (16 out of 48 patents)

9. Hans Jochen Lang (16 out of 43 patents)

10. Michael Kurz (15 out of 25 patents)

11. Karl Geisen (15 out of 34 patents)

12. Miles Hawley (15 out of 18 patents)

13. Joachim Brendel (14 out of 55 patents)

14. Ursula Schindler (14 out of 36 patents)

15. Volkmar Wehner (13 out of 63 patents)

Core Competencies:

Recombinant Platelet Collagen Receptor

Chimeric Antibody

Pyrazole Derivatives

Cyclohexapeptide Compounds

Antimycotic Gel

Oligonucleotide Derivatives

Angiotensin Receptor Agonists

Benzimidazole Derivatives

Vasopeptidase Inhibitors

Monoclonal Antibodies

Insulin Preparations

Factor Xa Inhibitors

330 patents: Sort by Forward Citations

1. 8278430 - Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use (2012-10-02),

2. 8198030 - Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use (2012-06-12),

3. 8048901 - 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals (2011-11-01),

4. 7968550 - Substituted N-aryl heterocycles, process for their preparation and their use as medicaments (2011-06-28),

5. 7928066 - Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use (2011-04-19),

6. 7662383 - Chimeric antibody against tumor associated antigens and its use in diagnosing tumors (2010-02-16),

7. 7300950 - Pyrazole derivatives, their preparation and their use in pharmaceuticals (2007-11-27),

8. 7166572 - Cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical (2007-01-23),

9. 7049341 - N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use (2006-05-23),

10. 7045649 - C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals (2006-05-16),

11. D520636 - Medical device for injecting fluid medicaments (2006-05-09),

12. 7026337 - Antimycotic gel having high active compound release (2006-04-11),

13. 7019028 - Endiandric acid H and its derivatives, process for their preparation and use thereof (2006-03-28),

14. 7019023 - Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use (2006-03-28),

15. 7018656 - Antimycotic gel with high active substance release (2006-03-28),

Aventis Pharma Deutschland, GmbH is a leading pharmaceutical company based in Germany. We specialize in the development, production, and distribution of innovative and high-quality pharmaceutical products. With a focus on research and development, we aim to discover new treatments and improve patients' lives. Our team of dedicated professionals works tirelessly to ensure the safety, efficacy, and accessibility of our medications. Visit our website to learn more about our product portfolio and the solutions we offer to healthcare professionals and patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

330 Patents

#1 in Franfurt am Main

#193 in Germany

#2,653 in the World

Franfurt am Main, Germany

Aventis Pharma Deutschland, Gmbh

Forward Citations = 3,420

433 inventors:

Martin Bickel (29 out of 65 patents)

Gerhard Jaehne (25 out of 59 patents)

Hans-Jochen Lang (22 out of 108 patents)

4. Heiner Glombik (22 out of 75 patents)

5. Heinz-Werner Kleemann (20 out of 103 patents)

Please report any incorrect information to support@idiyas.com

Loading…